Condition
Colorectal Cancer Liver Metastases (CRLM) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Colorectal Cancer Liver Metastases (CRLM) clinical trials that are recruiting, at sites in 10 countries (most in China (3), United States (2), Australia (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 10Countries
Newest Colorectal Cancer Liver Metastases (CRLM) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ctDNA methylation-guided adjuvant therapy after removing colorectal liver metastases | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Nov 4, 2026 |
| AK104 plus radiotherapy with standard first-line treatment for pMMR/MSS colorectal cancer liver metastases | Phase 2 | Shanghai | Recruiting | Apr 22, 2026 |
| AI-based prediction of liver metastasis after colorectal cancer surgery | — | Wuhan, Hubei | Recruiting | Feb 10, 2026 |
| Blood test using exosome microRNAs to find extrahepatic spread in colorectal cancer with liver metastases | — | Duarte, California | Recruiting | Nov 5, 2025 |
| Comparing two methods to induce liver regeneration in colorectal cancer patients | — | New Haven, Connecticut and 23 other locations | Recruiting | Jun 23, 2022 |
All recruiting trials (5)
-
ctDNA methylation-guided adjuvant therapy after removing colorectal liver metastases
This trial tests whether using a blood test that detects ctDNA methylation after surgery can guide adjuvant therapy for patients who had colorectal cancer spread to the liver and were operated on with no remaining disease.
-
AK104 plus radiotherapy with standard first-line treatment for pMMR/MSS colorectal cancer liver metastases
This trial will test whether adding AK104 and targeted liver radiotherapy to standard first-line therapy helps people with pMMR/MSS colorectal cancer that has spread to the liver.
-
AI-based prediction of liver metastasis after colorectal cancer surgery
This project will try a deep learning model that combines CT scans, digitized pathology slides, and routine clinical data to predict which stage I–III colorectal cancer patients are likely to develop liver metastases after curative surgery.
-
Blood test using exosome microRNAs to find extrahepatic spread in colorectal cancer with liver metastases
This project will test whether a blood test measuring exosome microRNAs can detect extrahepatic metastases in adults whose colorectal cancer has spread to the liver.
-
Comparing two methods to induce liver regeneration in colorectal cancer patients
This study is testing if a new method that combines two types of vein blockage can help colorectal cancer patients with liver issues regenerate their liver better than the standard method.
Related topics
Quick answers
How many Colorectal Cancer Liver Metastases (CRLM) clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in China (3 trials), United States (2 trials), Australia (1 trial), Austria (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.